Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 573 | 1,821 | 1,649 | 1,542 | 1,285 |
| Cost of Goods | 543 | 1,793 | 1,608 | 1,515 | 1,240 |
| Gross Profit | 30 | 28 | 41 | 27 | 45 |
| Operating Expenses | 2,251 | 2,109 | 2,104 | 2,241 | 1,863 |
| Operating Income | -1,678 | -1,288 | -1,455 | -1,699 | -1,578 |
| Other Income | 75 | 109 | 76 | 123 | 430 |
| Pre-tax Income | -1,603 | -1,179 | -1,379 | -1,576 | -1,148 |
| Net Income Continuous | -1,603 | -1,179 | -1,379 | -1,578 | -1,148 |
| Net Income | $-1,603 | $-1,179 | $-1,379 | $-1,578 | $-1,148 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.03 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.03 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.03 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.03 | -0.04 | -0.03 |
| EBITDA(a) | $-1,654 | $-1,260 | $-1,438 | $-1,684 | $-1,563 |